Home Articles List Article Information
Egyptian Journal of Zoology
Journal Archive
Volume Volume 81 (2024)
Volume Volume 80 (2023)
Volume Volume 79 (2023)
Volume Volume 78 (2022)
Volume Volume 77 (2022)
Volume Volume 76 (2021)
Volume Volume 75 (2021)
Volume Volume 74 (2020)
Volume Volume 73 (2020)
Volume Volume 72 (2019)
Volume Volume 71 (2019)
Volume Volume 70 (2018)
Volume Volume 69 (2018)
Volume Volume 68 (2017)
Volume Volume 67 (2017)
Volume Volume 66 (2016)
Volume Volume 65 (2016)
Volume Volume 64 (2015)
Volume Volume 63 (2015)
Volume Volume 62 (2014)
Volume Volume 61 (2014)
Volume Volume 60 (2013)
Volume Volume 59 (2013)
El-Sawah, S., El-Hallous, E., Khalil, D., Rashwan, H. (2022). AMELIORATING EFFECTS OF MESENCHYMAL STEM CELLS DRIVED FROM ADIPOSE AND BONE MARROW TISSUES ON CARDIOMYOPATHY OF DIABETIC RATS: A COMPARATIVE STUD. Egyptian Journal of Zoology, 77(77), 67-75. doi: 10.21608/ejz.2022.121278.1073
Shady G. El-Sawah; Ehab I. El-Hallous; Dlovan Y. Khalil; Hanan M. Rashwan. "AMELIORATING EFFECTS OF MESENCHYMAL STEM CELLS DRIVED FROM ADIPOSE AND BONE MARROW TISSUES ON CARDIOMYOPATHY OF DIABETIC RATS: A COMPARATIVE STUD". Egyptian Journal of Zoology, 77, 77, 2022, 67-75. doi: 10.21608/ejz.2022.121278.1073
El-Sawah, S., El-Hallous, E., Khalil, D., Rashwan, H. (2022). 'AMELIORATING EFFECTS OF MESENCHYMAL STEM CELLS DRIVED FROM ADIPOSE AND BONE MARROW TISSUES ON CARDIOMYOPATHY OF DIABETIC RATS: A COMPARATIVE STUD', Egyptian Journal of Zoology, 77(77), pp. 67-75. doi: 10.21608/ejz.2022.121278.1073
El-Sawah, S., El-Hallous, E., Khalil, D., Rashwan, H. AMELIORATING EFFECTS OF MESENCHYMAL STEM CELLS DRIVED FROM ADIPOSE AND BONE MARROW TISSUES ON CARDIOMYOPATHY OF DIABETIC RATS: A COMPARATIVE STUD. Egyptian Journal of Zoology, 2022; 77(77): 67-75. doi: 10.21608/ejz.2022.121278.1073

AMELIORATING EFFECTS OF MESENCHYMAL STEM CELLS DRIVED FROM ADIPOSE AND BONE MARROW TISSUES ON CARDIOMYOPATHY OF DIABETIC RATS: A COMPARATIVE STUD

Article 6, Volume 77, Issue 77, June 2022, Page 67-75  XML PDF (393.62 K)
Document Type: Short Communications
DOI: 10.21608/ejz.2022.121278.1073
View on SCiNiTO View on SCiNiTO
Authors
Shady G. El-Sawah email 1; Ehab I. El-Hallous1, 2; Dlovan Y. Khalil3; Hanan M. Rashwanorcid 1
1Zoology Department, Faculty of Science, Arish University, North Sinai, Egypt
2Biology Department, Faculty of Science, Taif University, Taif, Saudi Arabia
3Virology Department, Ministry of Health, Sulaymaniyah, Kurdistan, Iraq
Abstract
Diabetic cardiomyopathy (DCM) is considered one of the main diabetic complications, contributing to specific forms of heart failure independent from hypertension or ischemia. There are increased research efforts to further explore a new potential therapeutic strategy for preventing or reversing DCM progression. The present research aimed to explore which type of stem cell-based therapies could serve as an effective tool for the treatment of DCM in type 1 diabetic rats. Four groups of male Wistar rats have been used in this study including the control group, a diabetic-untreated group, and two diabetic rat groups treated with either mesenchymal stem cells (MSCs) derived from adipose tissue (AD-MSCs) or bone marrow (BM-MSCs). Interestingly, serum levels of heart dysfunction markers (LDH and CK-MB) in the diabetic rats were found to be declined to near-normal levels following injection with either of the two MSCs types. Also, BM-MSCs or AD-MSCs (1×106 cell/rat)-treated diabetic rats exhibited significant decreases in the cardiac xanthine oxidase activity, reactive oxygen species, and malondialdehyde level, accompanied with marked elevations in various antioxidants, compared with the diabetic untreated group.The results also clearly point out the excellence of AD-MSCs injection as a potential agent in alleviating the DCM over BM-MSCs injection.
Keywords
Antioxidant; Diabetic cardiomyopathy; Mesenchymal stem cells; Oxidative stress; Wistar rats
Main Subjects
Animal Physiology
Statistics
Article View: 196
PDF Download: 379